Agios Pharmaceuticals Inc (NASDAQ:AGIO)

108.70
Delayed Data
As of Jul 27
 -4.54 / -4.01%
Today’s Change
36.44
Today|||52-Week Range
138.85
-2.98%
Year-to-Date

Today’s Trading

Previous close113.24
Today’s open112.19
Day’s range-- - --
Volume578,815
Average volume (3 months)632,007
Market cap$4.2B
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)+43.82%
Earnings growth (this year)-31.17%
Earnings growth (next 5 years)--
Revenue growth (last year)+155.82%
P/E ratioNM
Price/Sales57.71
Price/Book9.90

Competitors

 Today’s
change
Today’s
% change
EXAMExamWorks Group Inc-0.51-1.53%
BRLIBio-Reference Labora...-0.67-1.46%
GNMKGenMark Diagnostics ...-0.66-6.76%
NEONeogenomics Inc-0.01-0.16%
Data as of 07/27/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$65.4M
Annual profit (last year)-$53.5M
Net profit margin-81.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Operating Officer
John Duncan Higgons
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers